tradingkey.logo

Basel Medical Group Ltd

BMGL
0.720USD
-0.020-2.70%
收盘 12/19, 16:00美东报价延迟15分钟
13.53M总市值
亏损市盈率 TTM

Basel Medical Group Ltd

0.720
-0.020-2.70%

关于 Basel Medical Group Ltd 公司

Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.

Basel Medical Group Ltd简介

公司代码BMGL
公司名称Basel Medical Group Ltd
上市日期Feb 25, 2025
CEOChhoa (Yen Feng)
员工数量77
证券类型Ordinary Share
年结日Feb 25
公司地址600 North Bridge Road, #12-02/03
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Singapore
邮编188778
电话6562919188
网址https://www.baselmedical.com
公司代码BMGL
上市日期Feb 25, 2025
CEOChhoa (Yen Feng)

Basel Medical Group Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月24日 周一
更新时间: 11月24日 周一
持股股东
股东类型
持股股东
持股股东
占比
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
其他
44.29%
持股股东
持股股东
占比
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
其他
44.29%
股东类型
持股股东
占比
Corporation
54.32%
Research Firm
0.58%
Hedge Fund
0.49%
Investment Advisor
0.47%
Investment Advisor/Hedge Fund
0.04%
其他
44.10%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
14
296.50K
0.70%
--
2025Q3
14
296.50K
0.70%
+165.18K
2025Q2
6
124.34K
0.00%
+124.34K
2025Q1
5
12.74M
67.81%
+12.74M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Rainforest Capital VCC
10.17M
54.16%
+10.17M
--
Feb 25, 2025
Marex Group plc
13.92K
0.07%
+13.92K
--
Jun 30, 2025
Virtu Americas LLC
16.18K
0.09%
+16.18K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
6.97K
0.04%
--
--
Aug 31, 2025
UBS Financial Services, Inc.
5.64K
0.03%
+5.64K
--
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Basel Medical Group Ltd的前五大股东是谁?

Basel Medical Group Ltd 的前五大股东如下:
Rainforest Capital VCC持有股份:10.17M,占总股份比例:54.16%。
Marex Group plc持有股份:13.92K,占总股份比例:0.07%。
Virtu Americas LLC持有股份:16.18K,占总股份比例:0.09%。
Geode Capital Management, L.L.C.持有股份:6.97K,占总股份比例:0.04%。
UBS Financial Services, Inc.持有股份:5.64K,占总股份比例:0.03%。

Basel Medical Group Ltd的前三大股东类型是什么?

Basel Medical Group Ltd 的前三大股东类型分别是:
Rainforest Capital VCC
Citadel Advisors LLC
Morgan Stanley & Co. LLC

有多少机构持有Basel Medical Group Ltd(BMGL)的股份?

截至2025Q4,共有14家机构持有Basel Medical Group Ltd的股份,合计持有的股份价值约为296.50K,占公司总股份的0.70%。与2025Q3相比,机构持股有所增加,增幅为--。

哪个业务部门对Basel Medical Group Ltd的收入贡献最大?

在--,--业务部门对Basel Medical Group Ltd的收入贡献最大,创收--,占总收入的--%。
KeyAI